Nevro Aims to Undo Boston Scientific Spinal Cord Therapy Win

Medical device giant Boston Scientific Corp. shouldn’t be able to escape patent infringement liability over its spinal cord stimulation devices, Nevro Corp. says.

Nevro, a Redwood City, Calif.-based medical technology company, hopes to convince the U.S. Court of Appeals for the Federal Circuit to undo a ruling finding Boston Scientific’s spinal cord stimulation (SCS) systems didn’t infringe Nevro’s patents. SCS is a pain treatment that works by sending electrical pulses to the spinal cord to interrupt pain signals.

The outcome of its appeal could significantly affect Nevro’s financial fortunes if the recent past is any guide. Nevro’s stock price plunged ...